This inventor holds 2 USPTO granted patents. Top assignee: Amgen Inc.. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Innovations of Partha Chakrabarti: A Visionary in Pharmaceutical Compounds
Introduction
Partha Chakrabarti is a prominent inventor based in Nagpur, India, known for his significant contributions in the field of pharmaceutical compounds. With two patents to his name, he has made strides in the development of innovative treatments for various inflammatory diseases.
Latest Patents
Chakrabarti's latest inventions include:
1. **Phthalazine Compounds and Methods of Use**: This invention introduces a new class of compounds beneficial for the prophylaxis and treatment of p38 kinase mediated diseases and inflammatory conditions. The compounds are detailed with a general Formula II, and pharmaceutical compositions using these compounds have potential applications for treating conditions like rheumatoid arthritis and psoriasis.
2. **Imidazo- and Triazolo-Pyridine Compounds and Methods of Use Thereof**: This patent also comprises a novel class of compounds aimed at treating protein kinase mediated diseases. Defined by a general Formula I, these compounds are formulated for pharmaceutical compositions targeting diseases such as rheumatoid arthritis and other inflammation disorders.
Career Highlights
Chakrabarti currently works at Amgen Inc., a biopharmaceutical company renowned for its innovative approaches to treating diseases. His research and development efforts have positioned him as a key player in the pharmaceutical field, contributing to breakthrough therapies that tackle challenging health issues.
Collaborations
In his career, he has collaboratively worked with respected colleagues such as Dawei Zhang and Andrew Stewart Tasker. These partnerships have further enriched his research endeavors, facilitating the advancement of his innovations.
Conclusion
Partha Chakrabarti exemplifies the essence of innovative thinking in pharmaceuticals. His dedication to addressing complex health challenges through his patented compounds marks him as a vital contributor to ongoing medical advancements. As the industry evolves, his work continues to offer promise in the realm of treatment options for inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile